The Clorox Company (NYSE:CLX) Holdings Cut by Tobam

Tobam decreased its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 16.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 221,333 shares of the company's stock after selling 44,057 shares during the quarter. Clorox accounts for about 2.8% of Tobam's investment portfolio, making the stock its 7th biggest position. Tobam owned 0.18% of Clorox worth $31,560,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Tyler Stone Wealth Management purchased a new position in Clorox during the 2nd quarter worth $25,000. Fortitude Family Office LLC bought a new stake in shares of Clorox in the fourth quarter valued at about $29,000. American National Bank lifted its stake in Clorox by 2,466.7% in the third quarter. American National Bank now owns 231 shares of the company's stock worth $30,000 after acquiring an additional 222 shares during the period. Strategic Investment Solutions Inc. IL bought a new stake in shares of Clorox in the 1st quarter valued at about $31,000. Finally, First Capital Advisors Group LLC. bought a new stake in shares of Clorox in the 2nd quarter valued at about $35,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Performance

Shares of Clorox stock traded down $0.33 during trading on Tuesday, hitting $144.02. 1,460,968 shares of the company's stock were exchanged, compared to its average volume of 1,234,833. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $178.21. The company has a debt-to-equity ratio of 11.37, a quick ratio of 0.57 and a current ratio of 0.89. The stock has a market capitalization of $17.87 billion, a price-to-earnings ratio of 228.61, a PEG ratio of 2.28 and a beta of 0.43. The business has a 50-day simple moving average of $151.56 and a 200-day simple moving average of $141.24.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $1.08. The business had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The company's revenue for the quarter was up 16.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.98 EPS. On average, research analysts forecast that The Clorox Company will post 5.51 EPS for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be paid a $1.20 dividend. The ex-dividend date is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a dividend yield of 3.33%. Clorox's dividend payout ratio is presently 761.92%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CLX. Barclays increased their target price on Clorox from $115.00 to $118.00 and gave the company an "underweight" rating in a research report on Tuesday, January 16th. UBS Group boosted their target price on shares of Clorox from $145.00 to $170.00 and gave the stock a "neutral" rating in a report on Friday, February 2nd. JPMorgan Chase & Co. increased their price target on shares of Clorox from $145.00 to $152.00 and gave the company a "neutral" rating in a research report on Thursday, January 18th. Jefferies Financial Group raised shares of Clorox from an "underperform" rating to a "hold" rating and set a $145.00 price objective on the stock in a research report on Tuesday, March 26th. Finally, DA Davidson reissued a "neutral" rating and set a $162.00 target price on shares of Clorox in a research report on Monday, February 5th. Four investment analysts have rated the stock with a sell rating and twelve have issued a hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $148.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.